Search results
Rival Covid-19 jab developers face off in High Court patent trial
PA Media: Science via Yahoo News· 2 days agoRival developers of Covid-19 jabs have faced off at the High Court in London as a weeks-long trial...
Pfizer (NYSE:PFE) Trading 0.9% Higher
ETF DAILY NEWS· 4 days agoShares of Pfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.9% during mid-day trading on Friday . The stock traded as high as $25.66 and last traded at $25.62. 10,092,678 ...
Pfizer (PFE) Scheduled to Post Quarterly Earnings on Wednesday
ETF DAILY NEWS· 2 days agoPfizer (NYSE:PFE – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Wednesday, May 1st. Pfizer has set its ...
New studies point to safety of COVID vaccines, but leave questions unanswered
KARE 11 Minneapolis-St. Paul· 14 hours ago“I felt like I was dying,” said Norkus. Two days following a booster dose of the Pfizer COVID-19...
J.W. Cole Advisors Inc. Boosts Stake in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 4 days agoJ.W. Cole Advisors Inc. raised its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 25.3% during the fourth quarter, according to its most recent disclosure with the Securities ...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 2 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
20 Counties with the Highest Cancer Rates in the US
Insider Monkey via Yahoo Finance· 2 hours agoIn this article, we will be taking a look at the 20 counties with the highest cancer rates in the US. If you do not want to learn about the global impact...
Pfizer Vs Moderna Battle Over COVID Vaccine Patents Begins in UK
US News & World Report· 2 days agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal ...
Ad group WPP trails rivals with decline in organic revenue By Reuters
Investing.com· 9 hours agoChief Executive Mark Read said the 1.6% decline was in line with expectations. "And we think the...
U.S. regulators give full approval to Pfizer COVID-19 vaccine
AOL· 6 days agoThe U.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious ...